News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Daily News European Societies Define Best Practices for Performing Renal Denervation Todd Neale February 21, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Renal Denervation a Third Option for Hypertension, European Experts Say Todd Neale September 17, 2021
News Conference News ESC 2021 ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients Todd Neale August 29, 2021
News Daily News Stenting for Aortic Coarctation Can Have Late Complications: COAST Caitlin E. Cox June 03, 2021
News Conference News ACC 2021 Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO Michael O'Riordan May 16, 2021
News Daily News Renal Denervation Lowers BP Across High-risk Groups: Global SYMPLICITY Registry Todd Neale June 09, 2020
News Daily News ‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues Todd Neale June 24, 2019
News Conference News EuroPCR 2019 Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation L.A. McKeown June 06, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2018 Caitlin E. Cox January 01, 2019